• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

门静脉高压症:病理生理学、诊断和治疗。

Portal hypertension: pathophysiology, diagnosis, and treatment.

机构信息

Department of Clinical Sciences, Tufts Cummings School of Veterinary Medicine, North Grafton, MA, USA.

出版信息

J Vet Intern Med. 2011 Mar-Apr;25(2):169-86. doi: 10.1111/j.1939-1676.2011.00691.x.

DOI:10.1111/j.1939-1676.2011.00691.x
PMID:21382073
Abstract

Portal hypertension (PH) is the result of increased vascular resistance in the portal circulation, increased portal venous blood flow, or both. In veterinary medicine, where portal pressure is seldom measured directly, the diagnosis of PH often is inferred from identification of associated complications including multiple acquired portosystemic shunts, ascites, and hepatic encephalopathy. Likewise, treatment of PH primarily is aimed at controlling these complications. The goal of this review is to provide an update on the pathophysiology, diagnosis, and treatment of PH. The review draws from information in the veterinary hepatology literature, reviews, and consensus statements in human hepatology and the literature on experimental models of PH.

摘要

门静脉高压症(PH)是门静脉循环中血管阻力增加、门静脉血流增加或两者共同作用的结果。在兽医领域,由于很少直接测量门静脉压力,PH 的诊断通常是从识别相关并发症推断出来的,包括多发性获得性门体分流、腹水和肝性脑病。同样,PH 的治疗主要旨在控制这些并发症。本综述的目的是提供门静脉高压症的病理生理学、诊断和治疗的最新信息。本综述借鉴了兽医肝病学文献、人类肝病学的综述和共识声明以及 PH 实验模型文献中的信息。

相似文献

1
Portal hypertension: pathophysiology, diagnosis, and treatment.门静脉高压症:病理生理学、诊断和治疗。
J Vet Intern Med. 2011 Mar-Apr;25(2):169-86. doi: 10.1111/j.1939-1676.2011.00691.x.
2
Management of portal hypertension and its consequences.
Vet Clin North Am Small Anim Pract. 1995 Mar;25(2):461-83. doi: 10.1016/s0195-5616(95)50037-3.
3
Effect of breed on anatomy of portosystemic shunts resulting from congenital diseases in dogs and cats: a review of 242 cases.品种对犬猫先天性疾病所致门体分流解剖结构的影响:242例病例回顾
Aust Vet J. 2004 Dec;82(12):746-9. doi: 10.1111/j.1751-0813.2004.tb13233.x.
4
An Unusual Case of Portal Hypertension Secondary to Primary Hypoplasia of the Portal Vein.门静脉原发性发育不全继发门静脉高压一例罕见病例。
J Am Anim Hosp Assoc. 2017 Nov/Dec;53(6):331-337. doi: 10.5326/JAAHA-MS-6428. Epub 2017 Sep 11.
5
Effects of vena caval banding in experimentally induced multiple portosystemic shunts in dogs.腔静脉结扎对实验诱导犬多门静脉分流的影响。
Am J Vet Res. 1993 Oct;54(10):1774-83.
6
Diagnosis and management of canine and feline liver diseases.犬猫肝脏疾病的诊断与管理
Tijdschr Diergeneeskd. 1986 Apr;111 Suppl 1:54S-57S.
7
Cirrhosis: a consequence of chronic liver disease.肝硬化:慢性肝病的一种后果。
Vet Clin North Am Small Anim Pract. 1985 Jan;15(1):151-76. doi: 10.1016/s0195-5616(85)50009-1.
8
Portosystemic vascular anomalies.门体静脉血管异常。
Vet Clin North Am Small Anim Pract. 2009 May;39(3):513-41. doi: 10.1016/j.cvsm.2009.02.004.
9
Congenital portosystemic shunts in the dog and cat.犬猫先天性门体分流
Vet Clin North Am Small Anim Pract. 1993 May;23(3):609-23. doi: 10.1016/s0195-5616(93)50309-1.
10
The sonographic search for portosystemic shunts.超声检查门静脉系统分流。
Clin Tech Small Anim Pract. 2007 Aug;22(3):104-14. doi: 10.1053/j.ctsap.2007.05.004.

引用本文的文献

1
Clinical efficacy of surgically assisted transjugular intrahepatic portosystemic shunt for cavernous transformation of portal vein.手术辅助经颈静脉肝内门体分流术治疗门静脉海绵样变性的临床疗效
World J Gastroenterol. 2025 Jul 21;31(27):108483. doi: 10.3748/wjg.v31.i27.108483.
2
Case Report: Successful surgical intervention for portal hypertension caused by primary hypoplasia of the portal vein in a dog.病例报告:犬门静脉原发性发育不全所致门静脉高压的成功手术干预。
Front Vet Sci. 2025 May 27;12:1582290. doi: 10.3389/fvets.2025.1582290. eCollection 2025.
3
Progressive hepatopathy after central division hepatectomy in a dog.
一只狗行肝中叶切除术后的进行性肝病
Aust Vet J. 2025 Jul;103(7):422-429. doi: 10.1111/avj.13452. Epub 2025 Jun 2.
4
Usefulness of Spleen Index and Alkaline Phosphatase Level for Predicting Post-Liver Biopsy Bleeding.脾脏指数和碱性磷酸酶水平对预测肝活检后出血的有用性。
JGH Open. 2025 May 20;9(5):e70183. doi: 10.1002/jgh3.70183. eCollection 2025 May.
5
Targeting Metabolism: Innovative Therapies for MASLD Unveiled.靶向代谢:非酒精性脂肪性肝炎的创新疗法揭秘。
Int J Mol Sci. 2025 Apr 25;26(9):4077. doi: 10.3390/ijms26094077.
6
The application of computational fluid dynamics in hepatic portal vein haemodynamics research: a narrative review.计算流体动力学在肝门静脉血流动力学研究中的应用:一篇叙述性综述。
Quant Imaging Med Surg. 2025 Mar 3;15(3):2605-2620. doi: 10.21037/qims-24-1593. Epub 2025 Feb 26.
7
Sleep Disorders: Pathogenesis and Therapeutic Interventions.睡眠障碍:发病机制与治疗干预
MedComm (2020). 2025 Mar 10;6(3):e70130. doi: 10.1002/mco2.70130. eCollection 2025 Mar.
8
Clinical Exploration and Physiologically Based Modelling of the Impact of Hepatic Impairment on Entrectinib Pharmacokinetics.肝功能损害对恩曲替尼药代动力学影响的临床探索与基于生理的建模
Clin Pharmacokinet. 2025 Mar;64(3):437-451. doi: 10.1007/s40262-024-01468-y. Epub 2025 Feb 11.
9
Spleno-Mesenteric Venous Blood Flow Dynamics in Adult Patients with Chronic Portal Vein Thrombosis Analyzed by Sequential CT-Spleno- and Mesenterico-Portography.通过连续CT脾门静脉造影和肠系膜门静脉造影分析成年慢性门静脉血栓形成患者的脾肠系膜静脉血流动力学
Life (Basel). 2025 Jan 20;15(1):129. doi: 10.3390/life15010129.
10
Endogenous C-type natriuretic peptide offsets the pathogenesis of steatohepatitis, hepatic fibrosis, and portal hypertension.内源性C型利钠肽可抵消脂肪性肝炎、肝纤维化和门静脉高压的发病机制。
PNAS Nexus. 2024 Dec 30;4(1):pgae579. doi: 10.1093/pnasnexus/pgae579. eCollection 2025 Jan.